Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2009
02/12/2009US20090042817 Use of an Active Ingredient Combination That Contains Hydroxystilbene for Preventing and/or Treating Diseases
02/12/2009US20090042808 Use of mitochondria-targeted electron scavengers as anti-inflammatory agents
02/12/2009US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release
02/12/2009US20090042800 Assay
02/12/2009US20090042799 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
02/12/2009US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use
02/12/2009US20090042783 Apo e analogs and methods for their use
02/12/2009US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy
02/12/2009US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection
02/12/2009US20090041857 Analgesic Cream
02/12/2009US20090041811 Oil-In-Water Emulsion Composition
02/12/2009US20090041793 Immunostimulatory Compositions and Uses Thereof
02/12/2009US20090041775 Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
02/12/2009US20090041758 Modified binding molecules comprising connecting peptides
02/12/2009US20090041739 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells
02/12/2009US20090041730 Joint Repair Using Mesenchymal Stem Cells
02/12/2009DE102004059357B4 Antikörper, welcher die Interaktion von humanem Thy-1 und dessen Liganden blockiert, sowie dessen Verwendung Antibody that blocks the interaction of human Thy-1 and its ligands, and its use
02/12/2009CA2696565A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
02/12/2009CA2695991A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
02/12/2009CA2695365A1 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
02/12/2009CA2695082A1 Peptide boronic acid and boronic ester compounds as proteasome inhibitors
02/12/2009CA2685002A1 Quinazoline compounds
02/11/2009EP2022785A1 Alkynylpyrimidines as Tie2 kinase inhibitors
02/11/2009EP2022782A1 Process for production of optically active piperidine compound
02/11/2009EP2022778A1 A crystalline form of (R,R)-tramadol-(S)-naproxene salt
02/11/2009EP2022775A2 Trihydroxy polyunsaturated eicosanoids
02/11/2009EP2022497A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-](3-hydroxy-1,2-benzisoxazol-6- yl)methoxy¨phenyl¨propionic acid or salt thereof
02/11/2009EP2021343A1 Imidazoazephinone compounds
02/11/2009EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase
02/11/2009EP2021330A2 Benzimidazole modulators of vr1
02/11/2009EP2021005A1 Methods and composition for treatment of inflammatory pain
02/11/2009EP1853601B1 Non steroidal glucocorticoid receptor modulators
02/11/2009EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
02/11/2009EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/11/2009CN101365700A Azaindazoles useful as inhibitors of kinases
02/11/2009CN101365685A 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the TRPV1 receptor
02/11/2009CN101365446A Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/11/2009CN101361980A Heparin phospholipid composite suitable for non-injection administration and preparation method thereof
02/11/2009CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
02/11/2009CN101361960A Medicine formulation for treating cervical vertebra pain and preparation method thereof
02/11/2009CN101361955A Traditional Chinese medicine combination for treating rheumatism
02/11/2009CN101361950A Gynaecologic traditional Chinese medicine capable of dispelling coldness, promoting blood and alleviating pain and preparation method thereof
02/11/2009CN101361935A Blood-activating emergency pill and preparation method thereof
02/11/2009CN101361931A Medicinal herbals fiber soft cushion and production method thereof
02/11/2009CN101361923A Traditional Chinese medicine for treating rheumatism
02/11/2009CN101361922A External drug for treating rheumatoid
02/11/2009CN101361921A Medicinal liquor for treating lumbago and scelagia
02/11/2009CN101361896A Traditional Chinese medicine composition for treating viscera inflammation
02/11/2009CN101361888A Traditional Chinese medicine for treating rheumatism and rheumatoid
02/11/2009CN101361882A Chinese medicine formulation for treating rheumatic osteoarthropathy
02/11/2009CN101361879A Gynaecologic traditional Chinese medicine capable of dispelling coldness, promoting blood and alleviating pain and preparation method thereof
02/11/2009CN101361873A Blood-activating emergency paste and preparation method thereof
02/11/2009CN101361868A Traditional Chinese medicine combination for treating rheumatism
02/11/2009CN101361867A Blood-nourishing myospasm relaxing pill and preparation method thereof
02/11/2009CN101361846A Detoxification fever-reduction traditional Chinese medicine for treating internal medical excess fire disease and production method thereof
02/11/2009CN101361839A Quality control detection method of Xuefu Zhuyu oral liquid
02/11/2009CN101361829A Traditional Chinese medicine for treating rheumatism, atrophic arthritis and preparation method thereof
02/11/2009CN101361824A Rheumatism treating medicine
02/11/2009CN101361823A Medicinal wine for treating injuries from falls, migraine
02/11/2009CN101361819A Novel external traditional Chinese medicine liniment capable of relaxing muscles and alleviating pain
02/11/2009CN101361818A Traditional Chinese medicine combination for treating shoulder-hand syndrome
02/11/2009CN101361786A Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides
02/11/2009CN101361785A Preparation method of alfalfa saponin
02/11/2009CN101361767A Medicine for relieving cough, eliminating sputum, relieving dyspepsia, promoting blood and dissipating blood stasis and preparation method thereof
02/11/2009CN101361759A Collateral vessel freeing and pain relieving capsule and preparation method thereof
02/11/2009CN101361713A Curcumin nano crystallization preparation and preparation method thereof
02/11/2009CN101361585A Honeysuckle effervescence decoction piece and manufacture technique thereof
02/11/2009CN101361550A Production method of sheet jelly
02/11/2009CN100460414C Stable vitamin B6 derivative
02/11/2009CN100460413C Chemical compound synthesized by carboxylic acid analog non-steroid anti-inflammatory agent and aminoglucose or salt, and synthesis method and uses thereof
02/11/2009CN100460387C S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
02/11/2009CN100460005C Medicine composition for treating rheumatism and rheumatoid arthritis
02/11/2009CN100460002C Chinese medicine composition for treating various kinds of inflammation and cyst
02/11/2009CN100460000C Preparation of Chinese traditional medicine for eliminating damp and promoting blood circulation to stop pain and preparation method thereof
02/11/2009CN100459999C Medicine for treating rheumatism
02/11/2009CN100459987C Effective part of astragalus, preparing method and application in pharmacy
02/11/2009CN100459986C Chinese medicine composition for treating rheumatoid disease
02/11/2009CN100459981C Pharmaceutical composition for treating traumatic injury
02/11/2009CN100459977C Skin penetrating paste of indomethacin albuterol
02/10/2009US7488811 Lacking cladinose in position 3, de(N-methyl)-descladinosyl-9-dihydro-erythromycin A; free of antibiotic properties; diseases related to an impaired cellular functionality of neutrophils, for instance rheumatoid arthritis, reperfusion ischaemia injury, septic shock, atherosclerosis
02/10/2009US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members
02/10/2009US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents
02/10/2009CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors
02/10/2009CA2386690C Pharmaceutical tramadol salts
02/10/2009CA2358448C Dispersible concentrate for the delivery of cyclosporin
02/10/2009CA2339299C Method of modulating memory effector t-cells and compositions
02/10/2009CA2328396C New substituted amides, their production and their use
02/10/2009CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
02/10/2009CA2208671C Substituted imides as tnf inhibitors
02/10/2009CA2186511C Pyrimidinyl derivatives as interleukin inhibitors
02/10/2009CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce)
02/05/2009WO2009018505A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
02/05/2009WO2009018389A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
02/05/2009WO2009018326A2 Soluble pyrone analogs methods and compositions
02/05/2009WO2009018169A1 Substituted cyclohexanols
02/05/2009WO2009017795A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers
02/05/2009WO2009017452A1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
02/05/2009WO2009017236A1 Pyridopyrimidin-4-one derivatives
02/05/2009WO2009017219A1 Inhibitor of binding of s1p1